Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer - Concepedia

Concepedia

Publication | Closed Access

Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer

441

Citations

16

References

2000

Year

Jan P. Neijt, Svend Aage Engelholm, Malgorzata Tuxen, Peter G. Sørensen, Mogens Hansen, Cristiana Sessa, C.A.M. de Swart, Fred R. Hirsch, Birthe Lund, Hans C. van Houwelingen

Journal of Clinical Oncology

Abstract

Paclitaxel-carboplatin is a feasible regimen for outpatients with ovarian cancer and has a better toxicity profile than paclitaxel-cisplatin.

References

	Year	Citations

Page 1